OB-GYN 101
Pharmacy

Contents  ·  Introduction  ·  Learning Objectives  ·  Clinical Issues  ·  Procedures  ·  Library  ·  Pharmacy  ·  Lab  ·  Chest X-ray  ·  Ultrasound  ·  Videos  ·  Forms  ·  Progress Notes  ·  Facts Cards  ·  Students  ·  Search  ·  Feedback  ·  About Us

 

 

Cimetadine (Tagamet)

Category:

  • Gastrointestinal

Description:

  • Antiulcer agent (H-2 receptor antagonist)

Indications:

  • Short term treatment of duodenal and benign gastric ulcers

  • Erosive gastroesophageal reflux disease (GERD)

  • Pathological hypersecretory conditions (Zollinger-Ellison syndrome, systemic mastocytosis, endocrine adenomas)

  • As part of multiple drug regiment to eradicate Helicobacter pylori in peptic ulcers

Drug Interactions:

  • Increased concentrations of interacting drugs with potential for toxicity: 

    • benzodiazepines

    • calcium channel blockers

    • carbamazepine

    • clozapine

    • cyclic antidepressants

    • glyburide

    • lomustine

    • melphalan

    • narcotic analgesics

    • nicotine

    • phenytoin

    • quinidine

    • tacrine

    • theophylline

    • tolbutamide

    • warfarin

  • Reduced concentrations of interacting drugs:

    • ketoconazole

    • cefuroxime

    • cefpodoxime

Precautions:

  • Pregnancy category B; excreted in breast milk

  • Smoking decreases effectiveness of cimetadine

  • Organic brain syndrome, hepatic disease, renal disease, elderly

Adverse Reactions (Side Effects):

  • Central Nervous System: anxiety, confusion, depression, dizziness, headache, psychosis, seizures, tremors, weakness

  • Cardiovascular: bradycardia, tachycardia

  • Gastrointestinal: abdominal cramps, diarrhea, jaundice, paralytic ileus

  • Genitourinary: Galactorrhea, gynecomastia, impotence

  • Hematological: Agranulocytosis, aplastic anemia, neutropenia, thrombocytopenia

  • Skin: Alopecia, exfoliative dermatitis, flushing rash, sweating, urticaria

 

 

 

Dosage:

Administered orally, intravenously, or intramuscularly

  • Treatment

    • PO 300mg four times daily with meals for 8 weeks or 400mg twice daily or 800mg at bedtime. After 8 weeks, give 300-400mg at bedtime only

    • IV bolus 300mg/20ml 0.9% NaCl over 1-2 minutes every 6 hours

    • IV INF 300mg/50ml D5W over 15-20 minutes every 6 hours

    • Continuous IV INF 37.5mg/hr (900mg/day)

    • IM 300mg every 6 hours not to exceed 2400mg daily.

  • Prophylaxis of duodenal ulcer: 

    • 400mg at bedtime

  • GERD: 

    • PO 800mg twice daily or 400mg four times daily for 12 weeks

 

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks. Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

OB-GYN 101: Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008 Medical Education Division, Brookside Associates, Ltd.
All rights reserved

 

Advertise on this site